Inhibition of NF-κB signaling by fasudil as a potential therapeutic strategy for rheumatoid arthritis

Arthritis and Rheumatism

Volumn 62, Issue 1, 2010, Pages 82-92

  Okamoto, Hiroshi ^a   Yoshio, Taku ^b   Kaneko, Hirotaka ^a   Yamanaka, Hisashi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FASUDIL; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; SYNAPTOTAGMIN I; 1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; CELL ADHESION MOLECULE; DRUG DERIVATIVE; PROTEIN KINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA BINDING; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPORTER GENE; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE; WESTERN BLOTTING; ANIMAL; ARTHRITIS; CELL ADHESION; CELL CULTURE; DRUG COMBINATION; DRUG EFFECT; GENETICS; LEWIS RAT; METABOLISM; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY; SYNOVIUM; TRANSCRIPTION INITIATION; VASCULAR ENDOTHELIUM;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CELL ADHESION; CELL ADHESION MOLECULES; CELLS, CULTURED; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; FEMALE; GENES, REPORTER; HUMANS; INTERLEUKIN-1BETA; NEUTROPHILS; NF-KAPPA B; PROTEIN KINASE INHIBITORS; RATS; RATS, INBRED LEW; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; TRANSCRIPTIONAL ACTIVATION;

EID: 74849140368     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.25063     Document Type: Article

References (42)

1. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 1996;85:307-10.
2. Hopkins SJ, Meager A. Cytokines in synovial fluid. II. The presence of tumour necrosis factor and interferon. Clin Exp Immunol 1988;73:88-92.
3. Okamoto H, Hoshi D, Kiire A, Yamanaka H, Kamatani N. Molecular targets of rheumatoid arthritis. Inflamm Allergy Drug Targets 2008;7:53-66.
4. Okamoto H, Cujec TP, Yamanaka H, Kamatani N. Molecular aspects of rheumatoid arthritis: role of transcription factors [review]. FEBS J 2008;275:4463-70.
5. Traenckner EB, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA. Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J 1995;14:2876-83.
6. Ghosh S, Karin M. Missing pieces in the NF-κB puzzle [review]. Cell 2002;109 Suppl:S81-96.
7. Okamoto T, Sakurada S, Yang JP, Merin JP. Regulation of NF-κB and disease control: identification of a novel serine kinase and thioredoxin as effectors for signal transduction pathway for NF-κB activation. Curr Top Cell Regul 1997;35:149-61.
8. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 1997;388:548-54.
9. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, et al. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 1997;278:860-6.
10. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 1997;91:243-52.
11. Rothwarf DM, Zandi E, Natoli G, Karin M. IKK-γ is an essential regulatory subunit of the IκB kinase complex. Nature 1998;395:297-300.
12. Nakano H, Shindo M, Sakon S, Nishinaka S, Mihara M, Yagita H, et al. Differential regulation of IκB kinase α and β by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc Natl Acad Sci U S A 1998;95:3537-42.
13. Ling L, Cao Z, Goeddel DV. NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176. Proc Natl Acad Sci U S A 1998;95:3792-7.
14. Lee FS, Peters RT, Dang LC, Maniatis T. MEKK1 activates both IκB kinase α and IκB kinase β. Proc Natl Acad Sci U S A 1998;95:9319-24.
15. Yang J, Lin Y, Guo Z, Cheng J, Huang J, Deng L, et al. The essential role of MEKK3 in TNF-induced NF-κB activation. Nat Immunol 2001;2:620-4.
16. Aya K, Alhawagri M, Hagen-Stapleton A, Kitaura H, Kanagawa O, Novack DV. NF-(κ)B-inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis. J Clin Invest 2005;115:1848-54.
17. Tas SW, Vervoordeldonk MJ, Hajji N, May MJ, Ghosh S, Tak PP. Local treatment with the selective IκB kinase β inhibitor NEMO-binding domain peptide ameliorates synovial inflammation. Arthritis Res Ther 2006;8:R86.
18. Okamoto H, Iwamoto T, Kotake S, Momohara S, Yamanaka H, Kamatani N. Inhibition of NF-κB signaling by fenofibrate, a peroxisome proliferator-activated receptor-α ligand, presents a therapeutic strategy for rheumatoid arthritis. Clin Exp Rheumatol 2005;23:323-30.
19. Asano T, Suzuki T, Tsuchiya M, Satoh S, Ikegaki I, Shibuya M, et al. Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase. Br J Pharmacol 1989;98:1091-100.
20. Asano T, Ikegaki I, Satoh S, Suzuki Y, Shibuya M, Takayasu M, et al. Mechanism of action of a novel antivasospasm drug, HA1077. J Pharmacol Exp Ther 1987;241:1033-40.
21. Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, et al. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg 1992;76:571-7.
22. Sato T, Asamitsu K, Yang JP, Takahashi N, Tetsuka T, Yoneyama A, et al. Inhibition of human immunodeficiency virus type 1 replication by a bioavailable serine/threonine kinase inhibitor, fasudil hydrochloride. AIDS Res Hum Retroviruses 1998;14:293-8.
23. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
24. Masuyama J, Minato N, Kano S. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture: T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by interferon. J Clin Invest 1986;77:1596-605.
25. Okamoto H, Cujec TP, Okamoto M, Peterlin BM, Baba M, Okamoto T. Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37. Virology 2000;272:402-8.
26. Haslett C, Guthrie LA, Kopaniak MM, Johnston RB Jr, Henson PM. Modulation of multiple functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 1985;119:101-10.
27. Yang JP, Merin JP, Nakano T, Kato T, Kitade Y, Okamoto T. Inhibition of the DNA-binding activity of NF-κB by gold compounds in vitro. FEBS Lett 1995;361:89-96.
28. Okamoto H, Katagiri Y, Kiire A, Momohara S, Kamatani N. Serum amyloid A activates nuclear factor-κB in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products. J Rheumatol 2008;35:752-6.
29. Bainbridge J, Sivakumar B, Paleolog E. Angiogenesis as a therapeutic target in arthritis: lessons from oncology. Curr Pharm Des 2006;12:2631-44.
30. Rooney M, Condell D, Quinlan W, Daly L, Whelan A, Feighery C, et al. Analysis of the histologic variation of synovitis in rheumatoid arthritis. Arthritis Rheum 1988;31:956-63.
31. Agarwal SK, Brenner MB. Role of adhesion molecules in synovial inflammation. Curr Opin Rheumatol 2006;18:268-76.
32. Dhawan SS, Quyyumi AA. Rheumatoid arthritis and cardiovascular disease. Curr Atheroscler Rep 2008;10:128-33.
33. Tabruyn SP, Griffioen AW. NF-κB: a new player in angiostatic therapy. Angiogenesis 2008;11:101-6.
34. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997;389:990-4.
35. Takayasu M, Suzuki Y, Shibuya M, Asano T, Kanamori M, Okada T, et al. The effects of HA compound calcium antagonists on delayed cerebral vasospasm in dogs. J Neurosurg 1986;65:80-5.
36. Hall A. Rho GTPases and the control of cell behaviour [review]. Biochem Soc Trans 2005;33(Pt 5):891-5.
37. Aspenstrom P. Effectors for the Rho GTPases. Curr Opin Cell Biol 1999;11:95-102.
38. Anwar KN, Fazal F, Malik AB, Rahman A. RhoA/Rho-associated kinase pathway selectively regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via activation of IκB kinase β and phosphorylation of RelA/p65. J Immunol 2004;173:6965-72.
39. Wei CY, Huang KC, Chou YH, Hsieh PF, Lin KH, Lin WW. The role of Rho-associated kinase in differential regulation by statins of interleukin-1β- and lipopolysaccharide-mediated nuclear factor κB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells. Mol Pharmacol 2006;69:960-7.
40. Bolick DT, Orr AW, Whetzel A, Srinivasan S, Hatley ME, Schwartz MA, et al. 12/15-lipoxygenase regulates intercellular adhesion molecule-1 expression and monocyte adhesion to endothelium through activation of RhoA and nuclear factor-κB. Arterioscler Thromb Vasc Biol 2005;25:2301-7.
41. Wittwer T, Schmitz ML. NIK and Cot cooperate to trigger NF-κB p65 phosphorylation. Biochem Biophys Res Commun 2008;371:294-7.
42. Hayashi T, Sekine T, Okamoto T. Identification of a new serine kinase that activates NFκB by direct phosphorylation. J Biol Chem 1993;268:26790-5.